JP2024506375A5 - - Google Patents
Info
- Publication number
- JP2024506375A5 JP2024506375A5 JP2023548848A JP2023548848A JP2024506375A5 JP 2024506375 A5 JP2024506375 A5 JP 2024506375A5 JP 2023548848 A JP2023548848 A JP 2023548848A JP 2023548848 A JP2023548848 A JP 2023548848A JP 2024506375 A5 JP2024506375 A5 JP 2024506375A5
- Authority
- JP
- Japan
- Prior art keywords
- dna
- composition according
- domain
- modification
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163149419P | 2021-02-15 | 2021-02-15 | |
| US63/149,419 | 2021-02-15 | ||
| PCT/US2022/016313 WO2022174144A1 (en) | 2021-02-15 | 2022-02-14 | Site-specific genome modification technology |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024506375A JP2024506375A (ja) | 2024-02-13 |
| JP2024506375A5 true JP2024506375A5 (cg-RX-API-DMAC10.html) | 2025-02-20 |
Family
ID=82837338
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023548848A Pending JP2024506375A (ja) | 2021-02-15 | 2022-02-14 | 部位特異的ゲノム修飾技術 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240229012A9 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4291664B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024506375A (cg-RX-API-DMAC10.html) |
| CN (1) | CN117222741A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022174144A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118620868A (zh) * | 2023-03-07 | 2024-09-10 | 上海科技大学 | IscBn-ωRNA编辑系统及其应用 |
| WO2024192291A1 (en) | 2023-03-15 | 2024-09-19 | Renagade Therapeutics Management Inc. | Delivery of gene editing systems and methods of use thereof |
| EP4771154A2 (en) | 2023-09-01 | 2026-07-08 | Renagade Therapeutics Management Inc. | Gene editing systems, compositions, and methods for treatment of vexas syndrome |
| EP4780955A1 (en) * | 2023-09-21 | 2026-07-29 | North Carolina State University | Programmable base editing |
| WO2025174765A1 (en) | 2024-02-12 | 2025-08-21 | Renagade Therapeutics Management Inc. | Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents |
| CN121495966B (zh) * | 2026-01-13 | 2026-04-17 | 山东大学 | 一种高效无痕编辑黏细菌基因组的方法及应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2728782T3 (es) * | 2012-05-25 | 2019-10-28 | Univ California | Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN |
| US20150044772A1 (en) * | 2013-08-09 | 2015-02-12 | Sage Labs, Inc. | Crispr/cas system-based novel fusion protein and its applications in genome editing |
| US20150166984A1 (en) * | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting alpha-antitrypsin point mutations |
| US10526590B2 (en) * | 2015-08-31 | 2020-01-07 | Agilent Technologies, Inc. | Compounds and methods for CRISPR/Cas-based genome editing by homologous recombination |
| WO2018152197A1 (en) * | 2017-02-15 | 2018-08-23 | Massachusetts Institute Of Technology | Dna writers, molecular recorders and uses thereof |
| CN110914310A (zh) * | 2017-03-10 | 2020-03-24 | 哈佛大学的校长及成员们 | 胞嘧啶至鸟嘌呤碱基编辑器 |
| US20220098619A1 (en) * | 2018-12-10 | 2022-03-31 | The Board Of Trustees Of The Leland Stanford Junior University | Anti-crispr-mediated control of genome editing and synthetic circuits in eukaryotic cells |
-
2022
- 2022-02-14 US US18/546,378 patent/US20240229012A9/en active Pending
- 2022-02-14 WO PCT/US2022/016313 patent/WO2022174144A1/en not_active Ceased
- 2022-02-14 EP EP22753488.0A patent/EP4291664B1/en active Active
- 2022-02-14 JP JP2023548848A patent/JP2024506375A/ja active Pending
- 2022-02-14 CN CN202280027473.3A patent/CN117222741A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240392303A1 (en) | RNA TARGETING OF MUTATIONS VIA SUPPRESSOR tRNAs AND DEAMINASES | |
| JP7698828B2 (ja) | Rnaを編集する方法および組成物 | |
| CN113631708B (zh) | 编辑rna的方法和组合物 | |
| US20250084397A1 (en) | Methods of purifying dna for gene synthesis | |
| US20240425902A1 (en) | Methods of purifying dna for gene synthesis | |
| Pelczar et al. | The host gene for intronic U17 small nucleolar RNAs in mammals has no protein-coding potential and is a member of the 5′-terminal oligopyrimidine gene family | |
| US20230125704A1 (en) | Modified bacterial retroelement with enhanced dna production | |
| JP2021118714A (ja) | Crispr系組成物及び使用方法 | |
| CN113994000A (zh) | 包括胞苷类似物的反义rna编辑寡核苷酸 | |
| EP3682004A2 (en) | Multiplex production and barcoding of genetically engineered cells | |
| JP2018522249A (ja) | Cas9分子/ガイドrna分子複合体の評価 | |
| JP7078946B2 (ja) | ゲノム編集方法 | |
| US20250146005A1 (en) | Methods of making circular rna | |
| EP4534675A1 (en) | Method for site-specific insertion of exogenous sequence in genome | |
| WO2023206871A1 (zh) | 一种优化的CRISPR/SpCas12f1系统、工程化向导RNA及其应用 | |
| WO2023206872A1 (zh) | 一种工程优化的核酸酶、向导rna、编辑系统和应用 | |
| GB2615901A (en) | Base editing enzymes | |
| JP7133856B2 (ja) | 細胞内在性のdna修飾酵素を利用して標的化したdnaの核酸塩基を特異的に変換する、細胞の核酸配列の変換方法、及びそれに用いる分子複合体 | |
| WO2025045078A1 (zh) | 一种用于调控rna甲基化修饰的编辑系统及其应用 | |
| EP4578946A1 (en) | Optimized guide rna, crispr/acc2c9 gene editing system, and gene editing method | |
| Sjakste et al. | Tightly bound to DNA proteins: possible universal substrates for intranuclear processes | |
| CN115725650B (zh) | 实现a到c和/或a到t碱基突变的碱基编辑系统及其应用 | |
| CN120004994A (zh) | 一种胞嘧啶脱氨酶抑制剂SflSddi及其应用 | |
| CN120944971A (zh) | 腺嘌呤碱基编辑器中腺嘌呤脱氨酶的静电重塑及其在全基因组消除脱靶效应的应用 | |
| CA3222964A1 (en) | Methods of treating asthma with solute carrier family 27 member 3 (slc27a3) inhibitors |